Role of SFRS13A in low-density lipoprotein receptor splicing

Human Mutation

Volumn 31, Issue 6, 2010, Pages 702-709

  Ling, I Fang ^a   Estus, Steven ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cholesterol; LDLR; SFRS13A; Splicing; SRp38

Indexed keywords

ISOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN RBMX; PROTEIN SFRS13A; PROTEIN SFRS3; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; REPRESSOR PROTEIN; SRSF10 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BRAIN TISSUE; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; BRAIN; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTMORTEM CHANGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HEP G2 CELLS; HUMANS; LIVER; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POSTMORTEM CHANGES; RECEPTORS, LDL; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA-BINDING PROTEINS; TRANSFECTION; YOUNG ADULT;

EID: 77952734299     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21244     Document Type: Article

References (33)

1. Antunes-Martins A, Mizuno K, Irvine EE, Lepicard EM, Giese KP. 2007. Sex-dependent up-regulation of two splicing factors, Psf and Srp20, during hippocampal memory formation. Learn Mem 14:693-702.
2. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X. 2000. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247. (Pubitemid 30052747)
3. Caceres JF, Kornblihtt AR. 2002. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 18:186-193.
4. Cao D, Fukuchi K, Wan H, Kim H, Li L. 2006. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging 27:1632-1643. (Pubitemid 44344838)
5. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. 2003. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
6. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
7. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, Wang H, Williams A, Blume JE. 2007. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8:R64.
8. Cooper TA, Wan L, Dreyfuss G. 2009. RNA and disease. Cell 136:777-793.
9. Elliott DJ, Venables JP, Newton CS, Lawson D, Boyle S, Eperon IC, Cooke HJ. 2000. An evolutionarily conserved germ cell-specific hnRNP is encoded by a retrotransposed gene. Hum Mol Genet 9:2117-2124.
10. Fryer JD, Demattos RB, McCormick LM, O'Dell MA, Spinner ML, Bales KR, Paul SM, Sullivan PM, Parsadanian M, Bu G, Holtzman DM. 2005. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J Biol Chem 280:25754-25759.
11. Han K, Yeo G, An P, Burge CB, Grabowski PJ. 2005. A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol 3:e158.
12. He Y, Smith R. 2009. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci 66:1239-1256.
13. Heinrich B, Zhang Z, Raitskin O, Hiller M, Benderska N, Hartmann AM, Bracco L, Elliott D, Ben-Ari S, Soreq H, Sperling J, Sperling R, Stamm S. 2009. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA. J Biol Chem 284:14303-14315.
14. Hobbs HH, Brown MS, Goldstein JL. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1:445-466.
15. Hofmann Y, Wirth B. 2002. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum Mol Genet 11:2037-2049. (Pubitemid 34919278)
16. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
17. Jumaa H, Guenet JL, Nielsen PJ. 1997. Regulated expression and RNA processing of transcripts from the Srp20 splicing factor gene during the cell cycle. Mol Cell Biol 17:3116-3124. (Pubitemid 27215026)
18. Kampa D, Cheng J, Kapranov P, Yamanaka M, Brubaker S, Cawley S, Drenkow J, Piccolboni A, Bekiranov S, Helt G, Tammana H, Gingeras TR. 2004. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res 14:331-342.
19. Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, Mason SM, Paul SM, Holtzman DM. 2009. Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular abeta clearance. Neuron 64:632-644.
20. Komatsu M, Kominami E, Arahata K, Tsukahara T. 1999. Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones. Genes Cells 4:593-606.
21. Krecic AM, Swanson MS. 1999. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363-371.
22. Lin S, Fu XD. 2007. SR proteins and related factors in alternative splicing. Adv Exp Med Biol 623:107-122.
23. Liu F, Gong CX. 2008. Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3:8.
24. Lynch KW, Maniatis T. 1995. Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev 9:284-293.
25. Ma K, Inglis JD, Sharkey A, Bickmore WA, Hill RE, Prosser EJ, Speed RM, Thomson EJ, Jobling M, Taylor K, Wolfe J, Cooke HJ, Hargreave TB, Chandley AC. 1993. A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 75:1287-1295.
26. Nasim MT, Chernova TK, Chowdhury HM, Yue BG, Eperon IC. 2003. HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. Hum Mol Genet 12:1337-1348.
27. Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME, Lorson CL, Lorson MA, Ben-Dov C, Fehlbaum P, Bracco L, Burghes AH, Bollen M, Stamm S. 2008. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum Mol Genet 17:52-70.
28. Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14:4336-4349.
29. Tazi J, Bakkour N, Stamm S. 2009. Alternative splicing and disease. Biochim Biophys Acta 1792:14-26.
30. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
31. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB. 2004. Systematic identification and analysis of exonic splicing silencers. Cell 119:831-845.
32. Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, Cupples LA, Estus S. 2007. A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Hum Mol Genet 16:1765-1772.
33. Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, Simpson JF, Tucker HM, Kelly JF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Bennett DA, Crook JE, Younkin SG, Estus S. 2008. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet 17:929-935.